High Cell Density Perfusion Process of Quail Cells Producing Oncolytic rVSV‐NDV
ABSTRACT Oncolytic viruses as agents for the treatment of various types of cancer have demonstrated their potential in many clinical studies over the past decades. In particular, rVSV‐NDV (a recombinant vesicular stomatitis virus [VSV] construct with fusogenic Newcastle disease virus glycoproteins)...
Saved in:
Main Authors: | Lennart Jacobtorweihe, Sven Göbel, Markus Wolschek, Jennifer Altomonte, Udo Reichl, Yvonne Genzel |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley-VCH
2025-07-01
|
Series: | Engineering in Life Sciences |
Subjects: | |
Online Access: | https://doi.org/10.1002/elsc.70035 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances in Oncolytic Viral Therapy in Melanoma: A Comprehensive Review
by: Ayushi Garg, et al.
Published: (2025-07-01) -
Therapy gone viral: Exploring the use of oncolytic viruses in non-small cell lung cancer immunotherapy
by: Jemima Steele, et al.
Published: (2025-01-01) -
Modern Approaches to Enterovirus-Based Oncolytic Immune Virotherapy of Malignant Diseases
by: E. R. Nemtsova, et al.
Published: (2025-07-01) -
Comparative safety and efficacy of oncolytic virotherapy for the treatment of individuals with malignancies: a systematic review, meta-analysis, and Bayesian network meta-analysisResearch in context
by: Poyee Lau, et al.
Published: (2025-08-01) -
Clinical trials on oncolytic viruses
by: I. V. Golovinov, et al.
Published: (2025-01-01)